"Matching" consent to purpose: The example of the Matchmaker Exchange.

Hum Mutat
Authors
Keywords
Abstract

The Matchmaker Exchange (MME) connects rare disease clinicians and researchers to facilitate the sharing of data from undiagnosed patients for the purpose of novel gene discovery. Such sharing raises the odds that two or more similar patients with candidate genes in common may be found, thereby allowing their condition to be more readily studied and understood. Consent considerations for data sharing in MME included both the ethical and legal differences between clinical and research settings and the level of privacy risk involved in sharing varying amounts of rare disease patient data to enable patient matches. In this commentary, we discuss these consent considerations and the resulting MME Consent Policy as they may be relevant to other international data sharing initiatives.

Year of Publication
2017
Journal
Hum Mutat
Volume
38
Issue
10
Pages
1281-1285
Date Published
2017 10
ISSN
1098-1004
DOI
10.1002/humu.23278
PubMed ID
28699299
PubMed Central ID
PMC5669800
Links
Grant list
UM1 HG008900 / HG / NHGRI NIH HHS / United States
U54 HG006542 / HG / NHGRI NIH HHS / United States
U41 HG006834 / HG / NHGRI NIH HHS / United States
Wellcome Trust / United Kingdom
U41 HG006627 / HG / NHGRI NIH HHS / United States
CIHR / Canada